Skip to main content
Erschienen in: Current Pulmonology Reports 4/2018

27.10.2018 | Invited Commentary

Assessment of Symptoms in Patients with COPD: Strengths and Limitations of Clinical Scores

verfasst von: Massimiliano Polastri, Nicolino Ambrosino, Michele Vitacca, Stefano Nava, Enrico Maria Clini

Erschienen in: Current Pulmonology Reports | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Health questionnaires are valuable tools to quantify, in an objective and standardised manner, the impact of chronic obstructive pulmonary disease on the health status of patients and on their well-being, and to track changes over time. Therefore, filling out these questionnaires allows clinicians to obtain the necessary information that can be easily related to clinical outcomes.

Recent Findings

Most importantly, symptoms’ assessment represents a very relevant part of these clinical tools when applied to patients suffering from chronic respiratory diseases. Comparing scores between visits is also indicative of the patient’s health status, as changes in quality of life are related to worse outcomes such as hospitalisation and exacerbation. However, each respiratory questionnaire may be peculiar in catching specific aspects of a similar symptom (i.e., dyspnoea); therefore, different tools are not interchangeable or comparable.

Summary

Detecting the minimal clinically important difference is a necessary evaluation procedure which affords the change in patient’s management and directs the therapeutic action towards more active treatments.
Literatur
8.
Zurück zum Zitat Gale N, Albarrati A, Munnery M, Tal-Singer R, Cockcroft J, Shale D. Factors associated with COPD mortality, 2 year follow-up data from the ARCADE study. Am J Crit Care Med. 2016;193:A3526 https://tinyurl.com/yb8xbn9l (accessed 29 September 2018). Gale N, Albarrati A, Munnery M, Tal-Singer R, Cockcroft J, Shale D. Factors associated with COPD mortality, 2 year follow-up data from the ARCADE study. Am J Crit Care Med. 2016;193:A3526 https://​tinyurl.​com/​yb8xbn9l (accessed 29 September 2018).
11.
Zurück zum Zitat Kim S, Oh J, Kim YI, Ban HJ, Kwon YS, Oh IJ, et al. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses. BMC Pulm Med. 2013;13:35. https://doi.org/10.1186/1471-2466-13-35. Kim S, Oh J, Kim YI, Ban HJ, Kwon YS, Oh IJ, et al. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses. BMC Pulm Med. 2013;13:35. https://​doi.​org/​10.​1186/​1471-2466-13-35.
13.
Zurück zum Zitat Smid DE, Franssen FME, Gonik M, Miravitlles M, Casanova C, Cosio BG, et al. Redefining cut-points for high symptom burden of the Global Initiative for Chronic Lung Disease classification in 18,577 patients with chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2017;18(12):1097.e11–1097.e24. https://doi.org/10.1016/j.jamda.2017.09.003.CrossRef Smid DE, Franssen FME, Gonik M, Miravitlles M, Casanova C, Cosio BG, et al. Redefining cut-points for high symptom burden of the Global Initiative for Chronic Lung Disease classification in 18,577 patients with chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2017;18(12):1097.e11–1097.e24. https://​doi.​org/​10.​1016/​j.​jamda.​2017.​09.​003.CrossRef
Metadaten
Titel
Assessment of Symptoms in Patients with COPD: Strengths and Limitations of Clinical Scores
verfasst von
Massimiliano Polastri
Nicolino Ambrosino
Michele Vitacca
Stefano Nava
Enrico Maria Clini
Publikationsdatum
27.10.2018
Verlag
Springer US
Erschienen in
Current Pulmonology Reports / Ausgabe 4/2018
Elektronische ISSN: 2199-2428
DOI
https://doi.org/10.1007/s13665-018-0217-0

Weitere Artikel der Ausgabe 4/2018

Current Pulmonology Reports 4/2018 Zur Ausgabe

Interstitial Lung Disease (A. Hajari Case, Section Editor)

Approved and Experimental Therapies for Idiopathic Pulmonary Fibrosis

Lung Transplant (R Bag, Section Editor)

Chronic Lung Allograft Dysfunction

Interstitial Lung Disease (A Hajari Case, Section Editor)

The Diagnostic Approach to Interstitial Lung Disease

Interstitial Lung Disease (A. Hajari Case, Section Editor)

Connective Tissue Related Interstitial Lung Disease

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.